Get startedLog in
    Picture of SpringWorks Therapeutics logo

    SWTX — SpringWorks Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapNeutral
    All News

    Brief: SpringWorks Announces Presentation Of More Data From Phase 3 DeFi Trial Of Nirogacestat

    Picture of SpringWorks Therapeutics logoSpringWorks Therapeutics
    25/05/2023 23:19
    May 25 (Reuters) - SpringWorks Therapeutics Inc
 SWTX.O :
    * SPRINGWORKS THERAPEUTICS ANNOUNCES PRESENTATION OF
ADDITIONAL
DATA FROM PHASE 3 DEFI TRIAL OF NIROGACESTAT IN ADULTS WITH
DESMOID TUMORS AT THE 2023 ASCO ANNUAL MEETING

Source text for Eikon:  ID:nGNX27VPbS 
Further company coverage:  SWTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on SpringWorks Therapeutics

    See all news